Australian biotech market today 06.05.09
Wednesday, 06 May, 2009
A very flat day’s trading today at 1.30pm, with the healthcare index down slightly along with the rest of the All Ordinaries.
The biotech majors (COH, CSL, RMD) regained some lost ground from yesterday, while Pharmaxis (ASX:PXS) is down a little after yesterday’s gains.
Novogen (ASX:NRT) is up a cent to 46c.
Singapore company SciGen (ASX:SIE) has told the ASX it is unaware of any reason why its stocks are experiencing turbulence at the moment – high volumes have been traded although the share price remains a tiny 12c.
The company appointed a new CEO and chairman a fortnight ago, with founder Saul Mashaal standing down.
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
argenx and Monash University partner against autoimmune diseases
To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...
